Results: 51-75/3068
Authors:
Ringhoffer, M
Schmitt, M
Karbach, J
Jager, E
Oesch, F
Arand, M
Citation: M. Ringhoffer et al., Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction, INT J ONCOL, 19(5), 2001, pp. 983-989
Authors:
Kim, R
Osaki, A
Kojima, J
Toge, T
Citation: R. Kim et al., Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer, INT J ONCOL, 19(5), 2001, pp. 991-996
Authors:
Kirikoshi, H
Inoue, S
Sekihara, H
Katoh, M
Citation: H. Kirikoshi et al., Expression of WNT10A in human cancer, INT J ONCOL, 19(5), 2001, pp. 997-1001
Authors:
Katoh, M
Citation: M. Katoh, Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer, INT J ONCOL, 19(5), 2001, pp. 1003-1007
Authors:
Liu, ZH
Uesaka, T
Watanabe, H
Kato, N
Citation: Zh. Liu et al., High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin, INT J ONCOL, 19(5), 2001, pp. 1009-1014
Authors:
Komata, T
Koga, S
Hirohata, S
Takakura, M
Germano, IM
Inoue, M
Kyo, S
Kondo, S
Kondo, Y
Citation: T. Komata et al., A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter, INT J ONCOL, 19(5), 2001, pp. 1015-1020
Authors:
Colombo, P
Gunnarsson, K
Iatropoulos, M
Brughera, M
Citation: P. Colombo et al., Toxicological testing of cytotoxic drugs (Review), INT J ONCOL, 19(5), 2001, pp. 1021-1028
Authors:
Murahashi, K
Yashiro, M
Takenaka, C
Matsuoka, T
Ohira, M
Chung, KHY
Citation: K. Murahashi et al., Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus, INT J ONCOL, 19(5), 2001, pp. 1029-1033
Authors:
Matsumoto, S
Teramoto, H
Nakamoto, M
Igishi, T
Kawasaki, Y
Shimizu, E
Citation: S. Matsumoto et al., Presence of antibodies against retinoblastoma tumor suppressor protein in patients with lung cancer, INT J ONCOL, 19(5), 2001, pp. 1035-1039
Authors:
Kim, IA
Yang, YJ
Yoon, SC
Choi, IB
Kay, CS
Kwon, HC
Kim, CM
Joe, YA
Kang, JK
Hong, YK
Citation: Ia. Kim et al., Potential of adenoviral p53 gene therapy and irradiation for the treatmentof malignant gliomas, INT J ONCOL, 19(5), 2001, pp. 1041-1047
Authors:
Tsai, MH
Chiou, SH
Chow, KC
Citation: Mh. Tsai et al., Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells, INT J ONCOL, 19(5), 2001, pp. 1049-1055
Authors:
Zhang, QS
Maddock, DA
Chen, JP
Heo, S
Chiu, C
Lai, D
Souza, K
Mehta, S
Wan, YS
Citation: Qs. Zhang et al., Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes, INT J ONCOL, 19(5), 2001, pp. 1057-1061
Authors:
Lee, BK
Diebel, E
Neukam, FW
Wiltfang, J
Ries, J
Citation: Bk. Lee et al., Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer, INT J ONCOL, 19(5), 2001, pp. 1063-1068
Authors:
Cosentini, E
Haberl, I
Pertschy, P
Teleky, B
Mallinger, R
Baumgartner, G
Wenzl, E
Hamilton, G
Citation: E. Cosentini et al., The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification, INT J ONCOL, 19(5), 2001, pp. 1069-1074
Authors:
Kim, R
Osaki, A
Toge, T
Citation: R. Kim et al., A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: The paradoxical role of Bcl-2 oncoprotein (Review), INT J ONCOL, 19(5), 2001, pp. 1075-1080
Authors:
Smolewski, P
Grabarek, J
Phelps, DJ
Darzynkiewicz, Z
Citation: P. Smolewski et al., Stathmo-apoptosis: Arresting apoptosis by fluorochrome-labeled inhibitor of caspases, INT J ONCOL, 19(4), 2001, pp. 657-663
Authors:
Nagata, S
Tanaka, S
Haruma, K
Kitadai, Y
Yoshihara, M
Shimamoto, F
Kohno, N
Chayama, K
Citation: S. Nagata et al., MUC1 and cathepsin D expression in early colorectal carcinoma showing V type pit pattern, INT J ONCOL, 19(4), 2001, pp. 665-672
Authors:
Jendrossek, V
Kugler, W
Erdlenbruch, B
Eibl, H
Lakomek, M
Citation: V. Jendrossek et al., Induction of differentiation and tetraploidy by long-term treatment of C6 rat glioma cells with erucylphosphocholine, INT J ONCOL, 19(4), 2001, pp. 673-680
Authors:
Kuniyasu, H
Abbruzzese, JL
Cleary, KR
Fidler, IJ
Citation: H. Kuniyasu et al., Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma, INT J ONCOL, 19(4), 2001, pp. 681-685
Authors:
Choi, YH
Citation: Yh. Choi, Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells, INT J ONCOL, 19(4), 2001, pp. 687-693
Authors:
Kubokawa, M
Nakashima, M
Yao, T
Ito, KI
Harada, N
Nawata, H
Watanabe, T
Citation: M. Kubokawa et al., Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer, INT J ONCOL, 19(4), 2001, pp. 695-700
Authors:
Shiozaki, K
Nakamori, S
Tsujie, M
Okami, J
Yamamoto, H
Nagano, H
Dono, K
Umeshita, K
Sakon, M
Furukawa, H
Hiratsuka, M
Kasugai, T
Ishiguro, S
Monden, M
Citation: K. Shiozaki et al., Human stomach-specific gene, CA11, is down-regulated in gastric cancer, INT J ONCOL, 19(4), 2001, pp. 701-707
Authors:
Teraoka, H
Sawada, T
Yamashita, Y
Nakata, B
Ohira, M
Ishikawa, T
Nishino, H
Hirakawa, K
Citation: H. Teraoka et al., TGF-beta 1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion, INT J ONCOL, 19(4), 2001, pp. 709-715
Authors:
Ishii, R
Takiguchi, N
Oda, K
Koda, K
Miyazaki, M
Citation: R. Ishii et al., Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer, INT J ONCOL, 19(4), 2001, pp. 717-722
Authors:
Satoh, M
Ito, A
Nojiri, H
Handa, K
Numahata, K
Ohyama, C
Saito, S
Hoshi, S
Hakomori, SI
Citation: M. Satoh et al., Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells, INT J ONCOL, 19(4), 2001, pp. 723-731